Results 231 to 240 of about 124,541 (336)

Sunitinib, a Clinically Used Anticancer Drug, Is a Potent AChE Inhibitor and Attenuates Cognitive Impairments in Mice.

open access: yesACS Chemical Neuroscience, 2016
Ling Huang   +21 more
semanticscholar   +1 more source

Constitutional symptoms and response to Penicillin G in erysipelas and cellulitis – a monocentric, retrospective, explorative study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Erysipelas, caused by streptococci, should be treated with penicillin, while uncomplicated cellulitis (phlegmon), often caused by Staphylococcus aureus, requires penicillinase‐resistant beta‐lactam antibiotics, which have a higher risk of adverse effects. Distinguishing between these infections is important.
Helena Schieffers, Cord Sunderkötter
wiley   +1 more source

Epilepsy treatment over time: The chess game analogy for choosing, adjusting, and adding antiseizure medications

open access: yesEpilepsia, EarlyView.
Abstract Recurrent seizures have such a negative impact upon the lives of persons with epilepsy that their prevention is a constant preoccupation of neurologists. Despite the large number of antiseizure medications (ASMs) currently available and of publications on their putative efficacy, adverse effects, and order of preference to start treatment ...
André Palmini   +2 more
wiley   +1 more source

The epileptologist's perspective of focal cortical dysplasia type 3: From concept to management

open access: yesEpilepsia, EarlyView.
Abstract The recent International League Against Epilepsy (ILAE) official and updated classification of focal cortical dysplasia (FCD) includes a third type—FCD type 3—characterized by architectural abnormalities (cortical dyslamination) associated with another “principal” lesion: hippocampal sclerosis (HS), developmental tumors, vascular malformations,
André Palmini   +10 more
wiley   +1 more source

From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with <i>in vivo</i>/<i>in vitro</i> validation and <i>in silico</i> insights. [PDF]

open access: yesJ Enzyme Inhib Med Chem
Fayed EA   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy